Related Experiment Video
Updated: Oct 18, 2025

Enhanced Gene Delivery and Expression using Intraosseous Injection of Chitosan Nanoparticles Encapsulated Adenine Base Editor Plasmids
Published on: May 16, 2025
Design of Experiments to Achieve an Efficient Chitosan-Based DNA Vaccine Delivery System
Carlos Rodolfo1, Dalinda Eusébio1, Cathy Ventura1
1CICS-UBI-Health Science Research Centre, University of Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal.
Abstract:
In current times, DNA vaccines are seen as a promising approach to treat and prevent diseases, such as virus infections and cancer. Aiming at the production of a functional and effective plasmid DNA (pDNA) delivery system, four chitosan polymers, differing in the molecular weight, were studied using the design of experiments (DoE) tool. These gene delivery systems were formulated by ionotropic gelation and exploring the chitosan and TPP concentrations as DoE inputs to maximize the nanoparticle positive charge and minimize their size and polydispersity index (PDI) as DoE outputs. The obtained linear and quadratic models were statistically significant (p-value < 0.05) and non-significant lack of fit, with suitable coefficient of determination and the respective optimal points successfully validated. Furthermore, morphology, stability and cytotoxicity assays were performed to evaluate the endurance of these systems over time and their further potential for future in vitro studies. The subsequent optimization process was successful achieved for the delivery systems based on the four chitosan polymers, in which the smallest particle size was obtained for the carrier containing the 5 kDa chitosan (~82 nm), while the nanosystem prepared with the high molecular weight (HMW) chitosan displayed the highest zeta potential (~+26.8 mV). Delivery systems were stable in the formulation buffer after a month and did not exhibit toxicity for the cells. In this sense, DoE revealed to be a powerful tool to explore and tailor the characteristics of chitosan/pDNA nanosystems significantly contributing to unraveling an optimum carrier for advancing the DNA vaccines delivery field.
Insights
This study optimized chitosan/plasmid DNA nanosystems for DNA vaccines using design of experiments. Results show tailored nanoparticles with small size and high charge, advancing DNA vaccine delivery.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Vaccine Development
Background:
- DNA vaccines offer a promising strategy for disease prevention and treatment, including viral infections and cancer.
- Effective delivery of plasmid DNA (pDNA) is crucial for DNA vaccine efficacy.
- Chitosan-based nanoparticles are explored as potential pDNA carriers due to their biocompatibility and mucoadhesive properties.
Purpose of the Study:
- To optimize chitosan/pDNA nanosystems for enhanced DNA vaccine delivery.
- To investigate the impact of chitosan molecular weight on nanoparticle characteristics.
- To utilize design of experiments (DoE) for efficient formulation development.
Main Methods:
- Formulation of chitosan/pDNA nanosystems via ionotropic gelation.
- Application of DoE to systematically vary chitosan and TPP concentrations.
- Analysis of nanoparticle size, polydispersity index (PDI), and zeta potential.
- Evaluation of nanoparticle morphology, stability, and cytotoxicity.
Main Results:
- Statistically significant models (p < 0.05) were obtained for optimizing nanosystem properties.
- The smallest particle size (~82 nm) was achieved with 5 kDa chitosan.
- The highest zeta potential (~+26.8 mV) was observed with high molecular weight (HMW) chitosan.
- Nanosystems demonstrated stability over one month and no significant cytotoxicity.
Conclusions:
- DoE is a powerful tool for tailoring chitosan/pDNA nanosystem characteristics.
- Optimized nanosystems show potential as effective carriers for DNA vaccines.
- Further in vitro studies are warranted to assess the full potential of these delivery systems.
More Related Videos
14:36Combining QD-FRET and Microfluidics to Monitor DNA Nanocomplex Self-Assembly in Real-Time
Published on: August 26, 2009
12:53Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
Published on: March 16, 2022